Who invested in Passage Bio?
Passage Bio's investors include Versant Ventures, OrbiMed, Vivo Capital, Access Industries and Lilly Asia Ventures, and 7 more on record.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$380Mraised across 3 rounds since 2019, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Endpts
Reported by Biocentury
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Passage Bio's investors include Versant Ventures, OrbiMed, Vivo Capital, Access Industries and Lilly Asia Ventures, and 7 more on record.
Passage Bio has raised $380M across 3 rounds since 2019.
Passage Bio's most recent round was an Undisclosed round of $154M in Jan 2021.
Its most recent round, $154M in Jan 2021, is also its largest on record.
Passage Bio's first round on record, in Feb 2019, was backed by Versant Ventures, Lily Asia and New Leaf and 2 others.
Passage Bio's latest named round is an Undisclosed round, in Jan 2021.
Passage Bio is based in the United States.
Access Industries led the Series B in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.